Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ritter

Showing results (21-30 of 905) with videos related to

Pageof 91
Sort By:
British Journal of Clinical Pharmacology|November 18, 2009
Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysisJ M Ritter
British Journal of Clinical Pharmacology|December 31, 2013
1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readersJames M Ritter
British Journal of Clinical Pharmacology|June 12, 2012
Sex, steroids and anabolic androgens in athleticsJames M Ritter
British Journal of Clinical Pharmacology|March 13, 2008
Minimising harm: human variation and adverse drug reactions (ADRs)J M Ritter
British Journal of Clinical Pharmacology|October 2, 2008
Prediction and reverse prediction in therapeutics and toxicologyJ M Ritter
The New England Journal of Medicine|April 4, 1991
Nitroglycerin to treat acute loss of visionJ M Ritter
British Journal of Clinical Pharmacology|August 8, 2009
Methods in clinical pharmacologyJ M Ritter
British Journal of Clinical Pharmacology|June 23, 2010
Human pharmacology of hydrogen sulfide, putative gaseous mediatorJ M Ritter
British Journal of Clinical Pharmacology|February 15, 2012
Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP)James M Ritter
British Journal of Clinical Pharmacology|August 10, 2011
Impact, orthodoxy and peer reviewJ M Ritter
Pageof 91

Showing results (21-30 of 905) with videos related to

Sort By:
Pageof 91
British Journal of Clinical Pharmacology|November 18, 2009
Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysisJ M Ritter
British Journal of Clinical Pharmacology|December 31, 2013
1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readersJames M Ritter
British Journal of Clinical Pharmacology|June 12, 2012
Sex, steroids and anabolic androgens in athleticsJames M Ritter
British Journal of Clinical Pharmacology|March 13, 2008
Minimising harm: human variation and adverse drug reactions (ADRs)J M Ritter
British Journal of Clinical Pharmacology|October 2, 2008
Prediction and reverse prediction in therapeutics and toxicologyJ M Ritter
The New England Journal of Medicine|April 4, 1991
Nitroglycerin to treat acute loss of visionJ M Ritter
British Journal of Clinical Pharmacology|August 8, 2009
Methods in clinical pharmacologyJ M Ritter
British Journal of Clinical Pharmacology|June 23, 2010
Human pharmacology of hydrogen sulfide, putative gaseous mediatorJ M Ritter
British Journal of Clinical Pharmacology|February 15, 2012
Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP)James M Ritter
British Journal of Clinical Pharmacology|August 10, 2011
Impact, orthodoxy and peer reviewJ M Ritter
Pageof 91